Privia Health Group Inc (PRVA) FinancialsPRVAPrivia Health Group Inc

Privia Health Group Inc (PRVA) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is FFS-patient care, accounting for 65.2% of total sales, equivalent to $412.64M. Other significant revenue streams include Capitated revenue and Shared savings. Understanding this composition is critical for investors evaluating how PRVA navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Privia Health Group Inc maintains a gross margin of 9.39%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 2.32%, while the net margin is 1.54%. These profitability ratios, combined with a Return on Equity (ROE) of 3.84%, provide a clear picture of how effectively PRVA converts its operational activities into shareholder value.

In the context of the broader market, PRVA competes directly with industry leaders such as CLOV and BHF. With a market capitalization of $2.88B, it holds a leading position in the sector. When comparing efficiency, PRVA's gross margin of 9.39% stands against CLOV's 100.00% and BHF's N/A. Such benchmarking helps identify whether Privia Health Group Inc is trading at a premium or discount relative to its financial performance.

Privia Health has shown strong revenue growth with Q2 2026 practice collections at $970 million, a 12.4% increase year-over-year. The adjusted EBITDA rose by 29% to $37.4 million, indicating improving profitability.